Bayer to increase patient access to specialty drugs with ZappRx digital platform

cafead

Administrator
Staff member
  • cafead   Jan 16, 2019 at 12:22: PM
via Bayer AG (Xetra:BAYN) gained access to a digital platform from ZappRx Inc. (Boston, Mass.) to improve patient access to Bayer's specialty drugs for pulmonary hypertension and relapsing-remitting multiple sclerosis (RRMS).

article source